Stock listing

INAF Stock Price, News, Filings & Events — Pt Indofarma Tbk Class B

Selected listing: INAF · IDX · IDR · ID

This page tracks Pt Indofarma Tbk Class B's INAF:IDX listing on IDX in IDR for ID, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following INAF:IDX. INAF:IDX is the stock-level entry point for investors researching Pt Indofarma Tbk Class B, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Pt Indofarma Tbk Class B, traded under the ticker INAF, is a public company based in Indonesia. With a market capitalization of approximately 21.48 million, the company operates in the pharmaceutical sector. Its focus is on providing healthcare solutions and products to meet the needs of the Indonesian market.

INAF:IDXIDRIDUpdated September 4, 2026
Pt Indofarma Tbk Class B logo
Ticker
INAF:IDX
Asset type
Stock
Market cap
$22.3M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
IDX
Currency
IDR

Pt Indofarma Tbk Class B INAF:IDX stock context

This page tracks Pt Indofarma Tbk Class B's INAF:IDX listing on IDX in IDR for ID, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following INAF:IDX. INAF:IDX is the stock-level entry point for investors researching Pt Indofarma Tbk Class B, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Pt Indofarma Tbk Class B, traded under the ticker INAF, is a public company based in Indonesia. With a market capitalization of approximately 21.48 million, the company operates in the pharmaceutical sector. Its focus is on providing healthcare solutions and products to meet the needs of the Indonesian market.

Latest news from Pt Indofarma Tbk Class B

All Pt Indofarma Tbk Class B news →

Research Pt Indofarma Tbk Class B